Research Sites

Clinical trial recruitment call script QA playbook

A QA playbook for clinical trial recruitment call scripts covering privacy, eligibility boundaries, approved language, escalation, and follow-up documentation.

Recruitment call-script QA helps teams standardize first-contact language, protect privacy boundaries, avoid eligibility promises, and route medical or consent-adjacent questions correctly.

In this guide

Key points

  • First-contact scripts should explain purpose, caller identity, study interest, and next action without implying eligibility.
  • Scripts should collect only the information needed for the approved step and route sensitive questions to the right owner.
  • QA should compare script language against actual call outcomes, repeated questions, escalations, and close reasons.

First contact is a control point

The first call after a patient submits interest can build trust or create expectation drift. A useful script gives coordinators consistent language while preserving space for approved workflow judgment.

FDA's recruiting guidance describes receptionist scripts as a common first-contact path and says IRBs should have assurance that personal and sensitive information gathered through those procedures will be appropriately handled. That makes the script an operating control, not just a convenience document.

Review the script for boundaries

The script should avoid eligibility promises, medical advice, study-benefit claims, and improvised consent language. It should also avoid collecting detailed sensitive information unless the approved workflow requires it at that step.

HHS explains the HIPAA minimum necessary standard as limiting use, disclosure, and requests for protected health information to what is needed for the purpose. Recruitment call scripts should reflect the same practical discipline: ask what the step requires, then route deeper review appropriately.

Tie QA to queue evidence

Script QA should not stop at a document review. Compare the script against actual repeated patient questions, escalation volume, no-response records, incomplete prescreens, and close reasons.

TrialsNest can support that review by keeping source, owner, status, next action, escalation, and close reason connected instead of buried in free-text notes.

Illustrative example

Case-style example

A three-site study uses three different first-contact scripts. One coordinator says a patient qualifies, another asks for detailed medication history immediately, and another only confirms callback timing.

Reporting shows inconsistent close reasons and uneven prescreen movement by site.

The team standardizes identity, purpose, approved prescreen prompts, escalation categories, and follow-up wording across locations.

Coordinator note

The script should make the first call easier, not turn coordinators into improvisers. If every coordinator explains the process differently, the source quality report will be noisy too.

Common mistakes

Starting with detailed medical questions

A first contact should not jump into sensitive detail before the patient understands who is calling, why, and what the study-team review path looks like.

No escalation lane

Questions about protocol interpretation, consent language, risk, study benefit, or medical judgment should have a named escalation route instead of being answered from memory.

Before you start

  • Confirm the opening: The first lines should identify the caller, the study or inquiry, and the reason for contact without pressure or eligibility promises.
  • Confirm the question boundary: Mark which questions are coordinator-owned, which are approved prescreen prompts, and which require escalation before response.
  • Confirm the close: The script should end with what happens next, who owns it, expected timing, and how the patient can ask questions or stop communication.
  • Does the script say who is calling and why within the first few seconds?
  • Does it avoid you qualify or you are eligible language?
  • Where does the coordinator route a question that belongs to investigator, sponsor, privacy, or consent review?
Sources and editorial notes

Published .

Operational call-script review guidance only. Scripts, prescreen questions, consent support, and participant communication should follow sponsor, IRB, investigator, and site-approved requirements.

This information is educational. Your study team makes medical, eligibility, and enrollment decisions.

See TrialsNest in action

Bring this workflow into one place.

Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.

Site clinical operations

Coordinator Today

Your inquiries, priorities, and upcoming visits.

Inquiries assigned
14
3 pending review
Visits today
6
4 in person · 2 virtual
Action priorities
4
Needs attention
Active studies
3
Study A · B · C
Daily priorities

Priority tasks

  • Review screening intakeInquiry 001 · Study A
    Completed
  • Verify specimen preparationStudy A · Due 10:00 AM
    Completed
  • Confirm visit windowInquiry 003 · Follow-up
    Pending
Today’s schedule

Upcoming visits

  1. In personInquiry 001

    Study A · Baseline visit

    View visit details →
  2. TelehealthInquiry 003

    Study A · Prescreen

    Review appointment →
  3. In personInquiry 004

    Study B · Week 4

    View visit details →

Keep reading